CTT Austin Logo
Film Strip 1
MedRebels welcomes practicing physicians to a cumulative 16-hour educational symposium and cadaveric workshop on cellular-based and regenerative therapies and their clinical applications for orthopaedics and pain management.  During this workshop, industry leaders will review current research and clinical studies, and they will address clinical pearls for implementing regenerative medicine into their practice.  Physicians will receive hands-on cadaveric training utilizing ultrasound-guidance and fluoroscopy.  They will also learn a variety of techniques for treating different musculoskeletal conditions.  Physicians also have an opportunity to learn about marketing strategies and how to incorporate the business of regenerative medicine.
 
KEYNOTE SPEAKER

PHILIPPE HERNIGOU, MD

Internationally renowned orthopaedic surgeon and clinical researcher, Dr. Philippe Hernigou serves as Chief of Orthopaedic Surgery at the Henri Mondor Hospital, East University at Paris, France.  He has published dozens of peer-reviewed articles and clinical studies, and he has treated over 5000 patients with bone marrow concentrate for over 25 years.  He is excited to share new data on Utilizing Bone Marrow Concentrate Therapy in the Elderly as well as the Effects of Donor Age on Progenitor Cell Content of Human Bone Marrow Aspirate and Mechnaically Disrupted Lipoaspirate.

philippe hernigou slider

TOPICS INCLUDE

  • Understanding mesenchymal stem cells, platelets, growth factors, and proteins

 

  • Protein power: alpha-2 macroglobulin & interleukin-1 receptor antagonist protein

 

  • Inflammatory components in arthritis

 

  • Effects of nitric oxide on cells

 

  • Pharmaceutical toxicity at the cellular level

 

  • Autologous versus allograft cell-based therapies
  • Platelet-rich plasma – leukocytes, platelets… what’s the best recipe?
  • Effects of age on cell count in bone marrow aspirate and lipoaspirate

 

  • Treating patients with infection and with previous cancer

 

  • Treating pathologies with MSCs: non-union, avascular necrosis, osteonecrosis, and discogenic back pain

 

  • Supercharging surgical repairs with MSCs and growth factors

 

  • Total joint versus cell-based therapies

 

  • The bioethics of orthobiologics

 

  • The business of regenerative medicine: marketing, training staff, talking with patients

Target Audience

 

This course is designed for physicians who are currently practicing and would like to learn more about cell-based therapies, as well as receive hands-on bone marrow aspiration and clinical application trainings.

Objectives

 

After attending this program, participants should be able to:
Understand the basic biological mechanisms of mesenchymal stem cells, platelets, growth factors, and proteins, and their role in the healing cascade
Interpret FDA Regulations regarding Human Cells and Tissue-based Products (HCT/Ps; 21 CFR 1271) and the Public Health Service (PHS) act

Utilize techniques that maximizes the recovery of MSCs, platelets, growth factors, and proteins

Apply new techniques for treating musculoskeletal conditions with regenerative medicine

Pricing

cell therapy training
GENERAL REGISTRATION
$2500.00

includes lectures, labs, meals, 16 CME credits

registration11
NON-CME REGISTRATION
$2000.00

includes lectures, labs, meals

registration33
SYMPOSIUM REGISTRATION
$2000.00

includes lectures, meals, 11 CME credits

panel2
NON-CME SYMPOSIUM
$1750.00

includes lectures, meals

Accreditation

 

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Amedco and MedRebels.  Amedco is accredited by the ACCME to provide continuing medical education for physicians.
Amedco designates this live activity for a maximum of 16 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.